November 09, 2022
Oncopeptides publishes Q3 report 2022
Media
November 09, 2022
Fusion Pharmaceuticals Announces Third Quarter 2022 Financial Results And Clinical Program Updates
November 03, 2022
Vicore announces new data from the IPF AIR trial further strengthening the benefit-risk profile of C21
November 03, 2022
Pulmonx Reports Third Quarter 2022 Financial Results
November 03, 2022
Interim report July-September 2022
November 03, 2022
Targovax ASA: Third quarter 2022 results
November 01, 2022
Carisma Therapeutics Announces Multiple Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 37th Anniversary Annual Meeting
October 27, 2022
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2022 interim report
October 27, 2022
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
October 26, 2022
Oncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufen